A
Aardvark Therapeutics Inc
NASDAQ:AARD
Aardvark Therapeutics Inc
NASDAQ:AARD
Price:
5.09
USD
-3.23%
Market Closed
Market Cap:
$110.8m
Balance Sheet
Balance Sheet Decomposition
Aardvark Therapeutics Inc
Aardvark Therapeutics Inc
Balance Sheet Decomposition is not available for
Aardvark Therapeutics Inc
Aardvark Therapeutics Inc
Balance Sheet
Aardvark Therapeutics Inc
Aardvark Therapeutics Inc
Currency: USD
| Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|
| Assets | ||||
| Cash & Cash Equivalents |
16
|
10
|
62
|
|
| Cash Equivalents |
16
|
10
|
62
|
|
| Short-Term Investments |
1
|
0
|
12
|
|
| Other Current Assets |
0
|
0
|
0
|
|
| Total Current Assets |
16
|
10
|
74
|
|
| PP&E Net |
0
|
0
|
1
|
|
| Other Long-Term Assets |
0
|
0
|
3
|
|
| Total Assets |
17
N/A
|
11
-37%
|
78
+636%
|
|
| Liabilities | ||||
| Accounts Payable |
0
|
1
|
2
|
|
| Accrued Liabilities |
0
|
0
|
2
|
|
| Short-Term Debt |
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
0
|
|
| Total Current Liabilities |
1
|
1
|
5
|
|
| Long-Term Debt |
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
|
| Total Liabilities |
1
N/A
|
1
+85%
|
5
+276%
|
|
| Equity | ||||
| Common Stock |
44
|
44
|
127
|
|
| Retained Earnings |
31
|
38
|
58
|
|
| Additional Paid In Capital |
3
|
3
|
4
|
|
| Total Equity |
16
N/A
|
9
-43%
|
72
+692%
|
|
| Total Liabilities & Equity |
17
N/A
|
11
-37%
|
78
+636%
|
|
| Shares Outstanding | ||||
| Common Shares Outstanding |
21
|
21
|
21
|
|
| Preferred Shares Outstanding |
0
|
0
|
97
|
|
Switch to:
Switch to:
See Also
Discover More
